Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-RNU5y6wj
December 8, 2023jessica-sacher
Biotech news Funding news Lysins AI

Yves Briers will head up Obulytix, a new company based on the phage lysin-based platform leveraging AI to tackle bacterial infections he co-developed at Ghent University and KU Leuven. Obulytix has already attracted $4 M Euro investment from Boehringer Ingelheim Venture Fund, Qbic, and Gemma Frisius Fund.

Loading ...
No comments yet. Be the first to comment!